Veru: Funding, Investors & Team (Sep 2026)
Veru is a biopharmaceutical enterprise specializing in the treatment of infectious diseases and cancer, particularly COVID-19 and other viral infections, as well as respiratory distress syndrome. They are dedicated to creating new medications to combat these conditions, and also offer options for the handling of breast and prostate cancers. The products they are currently working on include sabizabulin, enobosarm, zuclomiphene citrate, and various others.
Veru has raised $33.0M across 1 funding round on record, the most recent an undisclosed round of $33.0M announced in Dec 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Veru Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Veru Funding Rounds
Veru Founders and Leadership Team
No contact details are on record for this team yet.
Veru Funding Compared to Other Biotechnology Startups
Veru's latest round of $33.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Veru in Biotechnology and Miami
Companies Similar to Veru
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Veru Funding FAQs
What does Veru do?
Veru is a biopharmaceutical enterprise specializing in the treatment of infectious diseases and cancer, particularly COVID-19 and other viral infections, as well as respiratory distress syndrome. They are dedicated to creating new medications to combat these conditions, and also offer options for the handling of breast and prostate cancers. The products they are currently working on include sabizabulin, enobosarm, zuclomiphene citrate, and various others.
How much funding has Veru raised?
Veru has raised $33.0M across 1 round on record. The most recent is an undisclosed round of $33.0M announced in Dec 2023.
When did Veru last raise funding?
Veru's most recent funding round on record is an undisclosed round of $33.0M, announced in Dec 2023.
Who is the CEO of Veru?
Mitchell Steiner is listed as CEO at Veru.
Where is Veru headquartered?
Veru is based in Miami, Florida, United States.
How many employees does Veru have?
Veru is in the 251-500 employee band.
How does Veru's funding compare to other Biotechnology startups?
Veru's latest round of $33.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Veru Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Veru is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.